Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Paul

Showing results (1081-1090 of 1,117) with videos related to

Pageof 112
Sort By:
BMC Women'S Health|January 1, 2022
Cost-Effectiveness of perioperative Vaginally Administered estrogen in postmenopausal women undergoing prolapse surgery (EVA trial): study protocol for a multicenter double-blind randomized placebo-controlled trialEva V Vodegel, Sandra E Zwolsman, Astrid Vollebregt, et al.
Nature Cell Biology|September 5, 2018
Stem cell functionality is microenvironmentally defined during tumour expansion and therapy response in colon cancerKristiaan J Lenos, Daniël M Miedema, Sophie C Lodestijn, et al.
Blood|September 4, 2025
Acalabrutinib treatment for older (≥80 years old) and/or frail patients with CLL: primary end point analysis of the CLL-Frail trialFlorian Simon, Rudy Ligtvoet, Jan-Paul Bohn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2018
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin LymphomaMargaretha G M Roemer, Robert A Redd, Fathima Zumla Cader, et al.
Scientific Reports|January 17, 2020
Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classification systemsFrederike Dijk, Veronique L Veenstra, Eline C Soer, et al.
BMC Cancer|February 9, 2017
Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study designLisanne S Rigter, Manon C W Spaander, Leon M Moons, et al.
Nature|June 3, 2021
Apc-mutant cells act as supercompetitors in intestinal tumour initiationSanne M van Neerven, Nina E de Groot, Lisanne E Nijman, et al.
The Journal of Allergy and Clinical Immunology|November 21, 2015
Changes in IgE sensitization and total IgE levels over 20 years of follow-upAndré F S Amaral, Roger B Newson, Michael J Abramson, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker studyEnric Domingo, Luke Freeman-Mills, Emily Rayner, et al.
Thorax|March 26, 2018
Occupational exposures and 20-year incidence of COPD: the European Community Respiratory Health SurveyTheodore Lytras, Manolis Kogevinas, Hans Kromhout, et al.
Pageof 112

Showing results (1081-1090 of 1,117) with videos related to

Sort By:
Pageof 112
BMC Women'S Health|January 1, 2022
Cost-Effectiveness of perioperative Vaginally Administered estrogen in postmenopausal women undergoing prolapse surgery (EVA trial): study protocol for a multicenter double-blind randomized placebo-controlled trialEva V Vodegel, Sandra E Zwolsman, Astrid Vollebregt, et al.
Nature Cell Biology|September 5, 2018
Stem cell functionality is microenvironmentally defined during tumour expansion and therapy response in colon cancerKristiaan J Lenos, Daniël M Miedema, Sophie C Lodestijn, et al.
Blood|September 4, 2025
Acalabrutinib treatment for older (≥80 years old) and/or frail patients with CLL: primary end point analysis of the CLL-Frail trialFlorian Simon, Rudy Ligtvoet, Jan-Paul Bohn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 3, 2018
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin LymphomaMargaretha G M Roemer, Robert A Redd, Fathima Zumla Cader, et al.
Scientific Reports|January 17, 2020
Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classification systemsFrederike Dijk, Veronique L Veenstra, Eline C Soer, et al.
BMC Cancer|February 9, 2017
Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study designLisanne S Rigter, Manon C W Spaander, Leon M Moons, et al.
Nature|June 3, 2021
Apc-mutant cells act as supercompetitors in intestinal tumour initiationSanne M van Neerven, Nina E de Groot, Lisanne E Nijman, et al.
The Journal of Allergy and Clinical Immunology|November 21, 2015
Changes in IgE sensitization and total IgE levels over 20 years of follow-upAndré F S Amaral, Roger B Newson, Michael J Abramson, et al.
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker studyEnric Domingo, Luke Freeman-Mills, Emily Rayner, et al.
Thorax|March 26, 2018
Occupational exposures and 20-year incidence of COPD: the European Community Respiratory Health SurveyTheodore Lytras, Manolis Kogevinas, Hans Kromhout, et al.
Pageof 112